Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 2 of 5

Elizabeth Berry-Kravis from Rush University in Chicago, Illinois and lead at the mGluR drugs clinical trials funded by Novartis

Elizabeth Berry-Kravis, from Rush University in Chicago, is planning a new trial design for a mGluR blocker in fragile X syndrome

Source  Elizabeth Berry-Kravis